Related Experiment Videos
99mTc-gentamicin: chemical and biological evaluation
European Journal of Nuclear Medicine
|April 1, 1981
Summary
Technetium-99m labeled Gentamicin is a promising new agent for renal imaging. This study confirms its satisfactory scintigraphic delineation of kidneys with a high kidney-to-liver uptake ratio.
Area of Science:
- Nuclear medicine
- Radiopharmacy
- Renal imaging
Background:
- Development of novel radiopharmaceuticals is crucial for advancing diagnostic imaging.
- Renal studies require agents with specific organ distribution and high target-to-background ratios.
Purpose of the Study:
- To evaluate the preparation and organ distribution of a new agent, 99mTc-Gentamicin complex.
- To determine the suitability of 99mTc-Gentamicin for scintigraphic delineation of the kidneys.
Main Methods:
- Preparation of 99mTc-Gentamicin complex via pertechnetate reduction with stannous chloride.
- Organ distribution studies in rats.
- Paper chromatography using Whatman 3MM paper for labeling parameter analysis.
Main Results:
- Optimal labeling parameters were determined using organ distribution and chromatography.
- Higher stannous ion concentrations led to insoluble technetium species concentrating in the liver.
- A mean kidney:liver ratio of 10.4:1 was achieved 1 hour post-injection.
Conclusions:
- 99mTc-Gentamicin complex demonstrates favorable characteristics for renal imaging.
- The agent provides satisfactory scintigraphic delineation of the kidneys.
- The high kidney-to-liver ratio indicates good target uptake and low background interference.